Immunological lessons from CD28 deficiency in humans.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
08 07 2021
Historique:
entrez: 9 7 2021
pubmed: 10 7 2021
medline: 24 12 2021
Statut: ppublish

Résumé

In this issue of Cell, Casanova and colleagues examine three family members with a mutation that results in deficiency of the T cell co-stimulatory molecule CD28. These patients exhibit clinical symptoms due to human papillomavirus-2 and -4 infections, show increased levels of Epstein-Barr virus and cytomegalovirus in the blood, and respond poorly to vaccines.

Identifiants

pubmed: 34242561
pii: S0092-8674(21)00749-2
doi: 10.1016/j.cell.2021.06.014
pii:
doi:

Substances chimiques

CD28 Antigens 0

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

3595-3597

Commentaires et corrections

Type : CommentOn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Andreas Wieland (A)

Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, USA.

Rafi Ahmed (R)

Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA; Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: rahmed@emory.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH